» Articles » PMID: 28259623

Oral and Nasal Microbiota in Parkinson's Disease

Overview
Specialty Neurology
Date 2017 Mar 6
PMID 28259623
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Parkinson's disease (PD) is associated with neuropathological changes in olfactory and gastrointestinal tissues, and PD patients frequently suffer from hyposmia, hyposalivation, and dysphagia. Since hyposmia and gastrointestinal dysfunction are frequently premotor symptoms, it has been speculated that an external, for example microbial, agent could trigger the pathologic process in the corresponding organs, subsequently spreading to the central nervous system. We recently showed evidence for compositional differences between the fecal microbiota of PD patients and control subjects. In this study, our objective was to explore a possible connection between nasal and oral microbiota and PD.

Methods: We compared the oral and nasal bacterial communities of PD patients (oral: n = 72, nasal: n = 69) and control subjects (oral: n = 76, nasal: n = 67) using a 16S rRNA gene amplicon sequencing approach.

Results: Oral and nasal microbiota differed markedly from each other, with no notable similarity within subjects. Oral microbiota of PD patients and control subjects had differences in beta diversity and abundances of individual bacterial taxa. An increase in the abundance of opportunistic oral pathogens was detected in males, both with and without PD. Our data did not reveal convincing differences between the nasal microbiota of control subjects and PD patients.

Conclusion: The oral microbiome deserves additional research regarding its connection to PD and its biomarker potential. The higher abundance of oral pathogens in men underlines the importance of monitoring and promoting male dental health.

Citing Articles

Microbiota Orchestra in Parkinson's Disease: The Nasal and Oral Maestros.

Rei N, Grunho M, Mendes J, Fonseca J Biomedicines. 2024; 12(11).

PMID: 39594984 PMC: 11591639. DOI: 10.3390/biomedicines12112417.


Can salivary and skin microbiome become a biodetector for aging-associated diseases? Current insights and future perspectives.

Nurkolis F, Utami T, Alatas A, Wicaksono D, Kurniawan R, Ratmandhika S Front Aging. 2024; 5:1462569.

PMID: 39484071 PMC: 11524912. DOI: 10.3389/fragi.2024.1462569.


Oral and gut microbiome profiles in people with early idiopathic Parkinson's disease.

Stagaman K, Kmiecik M, Wetzel M, Aslibekyan S, Sonmez T, Fontanillas P Commun Med (Lond). 2024; 4(1):209.

PMID: 39443634 PMC: 11499922. DOI: 10.1038/s43856-024-00630-8.


Metagenome-assembled microbial genomes from Parkinson's disease fecal samples.

Duru I, Lecomte A, Shishido T, Laine P, Suppula J, Paulin L Sci Rep. 2024; 14(1):18906.

PMID: 39143178 PMC: 11324757. DOI: 10.1038/s41598-024-69742-4.


Whole-Genome Metagenomic Analysis of the Oral Microbiota in Patients with Obstructive Sleep Apnea Comorbid with Major Depressive Disorder.

Ye J, Lv Y, Xie H, Lian K, Xu X Nat Sci Sleep. 2024; 16:1091-1108.

PMID: 39100910 PMC: 11296376. DOI: 10.2147/NSS.S474052.